YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (5.2), the stock would be worth MYR2.25 (8% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.8 | MYR2.08 |
0%
|
| 3-Year Average | 5.2 | MYR2.25 |
+8%
|
| 5-Year Average | 5.5 | MYR2.39 |
+15%
|
| Industry Average | 12.5 | MYR5.42 |
+160%
|
| Country Average | 12.6 | MYR5.46 |
+163%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
295m MYR | 4.8 | 11.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
835.2B USD | 29.2 | 40.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.8B USD | 21.4 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 13.4 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 21.9 | 28 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223.1B CHF | 15.6 | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.9B USD | 11.5 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 970 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 9.8 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 10.1 | 19.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.2B USD | 8.9 | 16.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 8.2 |
| Median | 12.6 |
| 70th Percentile | 20 |
| Max | 116 799.5 |
Other Multiples
YSP Southeast Asia Holding Bhd
Glance View
Y.S.P.Southeast Asia Holding Bhd. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2004-01-12. Southeast Asia Holding Bhd. is a Malaysia-based investment holding company that is primarily engaged in the provision of management services. The Company’s segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in manufacturing of pharmaceutical products. The Trading segment is involved in import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Investment holding segment is engaged in investment holding. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which is engaged in providing management services, such as product registration trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacture of biotechnology products and health products.
